Stibbe remains highly active across the full spectrum of debt finance matters, with a team that is capable of handling leveraged private equity financings and real estate finance while maintaining a particularly strong focus on assisting both lenders and borrowers with financings for projects and joint ventures in the energy and infrastructure space. Debt capital markets and securitisation expert Pieter Nobels further extends the practice's offering by enabling it to advise private and institutional lenders on cross-border bond issuances and uptierings. Wouter Ghijsels leads the team and is a key contacted for both syndicated and direct lending, especially in the context of acquisition and project finance. Pieter-Jan Leemen is also highly recommended for syndicated lending matters.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Whenever there seems to be no way out, Stibbe finds a way to overcome the legal hurdles and find an creative out of the box and acceptable solution. The high success rate in their solutions is remarkable.’
‘Good involvement of senior (partner) who is experienced, and also mid level Stibbe colleagues deliver value for money and are experienced’
‘Wouter Ghijsels is well-involved, very experienced, approachable, pragmatic. The same applies to Pieter-Jan Leemen.’
‘Quick responses. Able to assist the Client with relevant internal info. Easy to share and update documents with.’

Work highlights

Assisted Gigarant with the granting of a €500m guarantee in the framework of the €3.5bn project financing for the new plant to be constructed by INEOS in Antwerp.
Advised Highbridge Capital Management and Whitebox Advisors on the distressed “uptiering” restructuring of convertible bonds issued by Belgian biotech company Biocartis, through the issuance of a new 1st lien term loan, 2nd lien secured convertible bonds, new equity shares, and the amendment & extension of the existing unsecured convertible bonds.
Advised Carpenter Corporatio on the development and implementation of a "white knight" strategy and implementation of a poison pill in the course of hostile public takeover bid by Greiner on the shares of Euronext Brussels' listed Recticel.